Professional Documents
Culture Documents
NOORAIN CHANNA
05-171211-122
SECTION: V-D
DATE OF SUBMISSION: 11th June 2023
1
MHP-1
Q) Write a detailed note on the Etiology, Prevalence, and Prognostic Factors of spectrum of
“Depressive Disorders” as outlined in DSM-5-TR.
ETIOLOGY
More than one factor can be the cause of depression. It includes biological factors as genetic,
neurological, hormonal, immunological, and neuroendocrinological mechanisms appear to be
involved in the development of major depression, many of which are related to responses to
stressors and processing of emotional information. Secondly, talking about environmental
and personal vulnerabilities, Etiological models for depression are largely diathesis-stress
models in which stressful experiences trigger depression in those who may be vulnerable due
to biological and psychosocial characteristics and circumstances. Environmental stressors
associated with depression include acute life events, chronic stress, and childhood exposure
to adversity. Individuals vulnerabilities associated with depression include cognitive,
interpersonal and personal factors. A combination of biological, environmental, and personal
vulnerabilities contributes to the development of depression and can be affected in a two-way
process by depressive states. The majority of women experience depression during and after
pregnancy due to the hormonal changes in the body along with social pressure and low
support from family and society. Genetic vulnerability is also a cause of depression, people
are prone to major depression if it runs in the family.
2
MHP-1
3
MHP-1
liability. Women may also be at risk for depressive disorders during specific reproductive life
stages, including in the premenstrual period, postpartum, and perimenopause.
iv. Course modifiers:
All mood disorders including, anxiety, substance use, trauma and obsessive compulsive play
a role in developing depression.
3. PERSISTENT DEPRESSIVE DISORDER
Prevalence
The 12-month prevalence of dysthymia in the United States is approximately 0.5%.
Chronic major depressive disorder is 1.5%, and female prevalence is approximately 1.5 and 2
times higher than male prevalence for each of these diagnoses, respectively. The lifetime
prevalence of persistent depressive disorders in the United States is estimated at
approximately 2.5%.
Prognostic Features
i. Temperamental
Factors that predict poor long-term outcome include higher levels of negative affect
(neuroticism), more severe symptoms, lower systemic functioning, and the presence of
anxiety or behavioral disturbances.
ii. Environmental:
Early childhood risk factors include the death or separation of parents and childhood
adversity.
iii. Genetic and physiological:
There are no clear differences in disease onset, disease course, or family history between
DSMIV dysthymia disorder and chronic major depressive disorder. Therefore, early findings
on both disorders should also apply to persistent depressive disorders. Therefore, individuals
with ongoing major depressive disorder may have a higher proportion of first-degree relatives
with ongoing major depressive disorder than those with non-chronic major depression and
other depressive disorders in general Some brain regions (e.g. prefrontal cortex, anterior
cingulate cortex, amygdala, hippocampus) have been implicated in persistent depressive
disorder. Possibility of polysomnography abnormalities too.
4
MHP-1